№ files_lp_4_process_3_116415
Clinical guidance source summarizing treatment protocols, drug options, adjunctive therapies, and secondary prevention strategies for Pneumocystis pneumonia in immunocompromised adults.
Year: 2023
Region / Organization: CDC, NIH, HIVMA, IDSA, ASOT
Target Population: HIV patients, Solid Organ Transplant recipients
Disease Severity: Mild-Moderate, Moderate-Severe
First-Line Treatment: TMP-SMX 15-20mg/kg
Alternative Treatments: IV Pentamidine, Clindamycin-Primaquine, Dapsone-TMP, Atovaquone, Caspofungin
Adjunctive Therapy: Corticosteroids, Antiretrovirals
Duration of Therapy: 14–21 days
Secondary Prevention: Yes, until CD4 recovery for HIV; lifelong for transplant patients
Treatment Failure Strategy: Wait 4–8 days before switching; preferred alternatives noted
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.